5-MeO-AET
From Wikipedia, the free encyclopedia
5-MeO-AET
|
|
Systematic (IUPAC) name | |
1-(5-methoxy-1H-indol-3-yl)butan-2-amine | |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | ? |
Chemical data | |
Formula | C13H18N2O |
Mol. mass | 218.30 g/mol |
SMILES | & |
Physical data | |
Melt. point | 201–203 °C (394–397 °F) |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
5-MeO-α-ET is a tryptamine that produces psychedelic, entactogenic, and stimulant effects.
Contents |
[edit] Chemistry
5-MeO-α-ET is short for 5-methoxy-alpha-ethyltryptamine. The full name of the chemical is 1-(5-methoxy-1H-indol-3-yl)butan-2-amine. 5-MeO-α-ET is a tryptamine, which belong to a larger family of compounds known as indolethylamines. 5-MeO-α-ET is closely related to the compounds 5-MeO-AMT and α-ET.
[edit] Dosage
5-MeO-α-ET, when used recreationally, is usually taken orally at dosages of 50-75 mg.
[edit] Effects
5-MeO-α-ET produces entactogenic and stimulant effects that can last 4-6 hours. However, little information exists on the psychopharmacological of this compound, thus considerable variation with regard to dosage and effects can be expected.
[edit] Dangers
There have been no reported deaths or hospitalizations from 5-MeO-α-ET, but its safety profile is unknown.
[edit] Legality
5-MeO-α-ET is unscheduled and uncontrolled in the United States, but possession and sales of 5-MeO-α-ET could be prosecuted under the Federal Analog Act because of its structural similarities to α-ET and α-MT.
[edit] External links
|